CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 4 Open-market sale Chief Operating Officer sold 384 shares at $3.52 ($1,352)
- 4 Open-market sale VP, Finance sold 1,114 shares at $3.52 ($3,921)
- 4 Open-market sale Chief Operating Officer sold 457 shares at $3.53 ($1,613)
- 4 Open-market sale S.V.P., General Counsel sold 458 shares at $3.51 ($1,608)
- 4 Open-market sale BRISTOW MICHAEL R sold 752 shares at $3.50 ($2,632)
- 4 Open-market sale VP, Finance sold 160 shares at $3.46 ($554)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 496 shares at $5.14 ($2,549)
- 4 Open-market sale BRISTOW MICHAEL R sold 1,809 shares at $6.33 ($11,451)
- 4 Open-market sale VP, Finance sold 476 shares at $6.23 ($2,965)
- 4 Open-market sale S.V.P., General Counsel sold 1,129 shares at $6.32 ($7,135)
- 4 Open-market sale Chief Operating Officer sold 680 shares at $6.33 ($4,304)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 11 of 23 · 459 filings